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21 Abstract
22 Alix/AIP1 is an adaptor protein involved in apoptosis, endocytic membrane trafficking 
23 and brain development. Alix has been found within the human postsynaptic density 
24 (PSD) and since NMDA receptors (NMDARs) are central components of the PSD, we 
25 hypothesized that the close proximity of both proteins may allow Alix to influence the 
26 downstream pathways following NMDAR activation. NMDARs play important roles in 
27 excitotoxicity and we evaluated the effects of recombinant Alix in an NMDAR cell 
28 death assay. Overexpression of Alix with NMDARs increased the potency of NMDAR 
29 induced cell death compared to cells only expressing NMDARs and this requires 
30 expression of the Alix C-terminal region. Therefore we demonstrate a previously 
31 unreported role for Alix as a potential modulator of NMDAR function.
32 Keywords: ALG-2, Alix/AIP1, calcium, dopamine receptor interacting protein, 
33 excitotoxicity, glutamate receptor, neurodegeneration, PDCD6IP, postsynaptic density 
34 Abbreviations
35 ALG-2, apoptosis-linked gene 2, AIP1, ALG-2 interacting Protein 1, APV, 2R-amino-5-
36 phosphonopentanoate, PSS, Physiological Salt Solution, NMDA, N-methyl-D-aspartate
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38 Introduction
39 Glutamate induced neuronal cell death via NMDAR excitotoxicity is thought to 
40 contribute to many neurodegenerative processes within the mammalian CNS [1]. The 
41 influx of Ca2+ through NMDARs is vital for cell death to occur and is important for 
42 stimulating a variety of intracellular signaling cascades although the precise molecular 
43 mechanisms of Ca2+ dependent cytotoxicity still remain unclear [2]. The roles of 
44 NMDARs in neuronal death are complex and the synaptic or extrasynaptic location of 
45 NMDARs can influence the pathways leading to neuroprotection or neurotoxicity [3]. 
46 NMDARs are ligand-gated heteromeric ion channels composed of GluN1 and GluN2 
47 subunits and the incorporation of the different GluN2 subunits (A-D) is a major 
48 determinant of both physiological and pathological NMDAR properties [4,5]. 
49 ALG-2 interacting protein (apoptosis-linked gene 2-interacting protein X 
50 /Alix/AIP1/PDCD6IP) is an ubiquitous adaptor protein that was first described for its 
51 capacity to bind to the calcium-binding protein, Apoptosis-linked gene-2 (ALG-2) [6,7]. 
52 It is known to be involved in apoptosis, regulation of cell adhesion, protein sorting, 
53 adaptation to stress conditions, ESCRT (endosomal sorting complex required for 
54 transport), brain development and neuronal cell death [8-13]. Furthermore, it has been 
55 identified as a novel dopamine receptor interacting protein, using D1 receptor C-terminal 
56 domain or D3 receptor third cytoplasmic loop as 'baits' in separate yeast two-hybrid 
57 screens [14]. Although there is clear evidence of Alix playing important roles in neuronal 
58 function [15,16], the precise purpose of Alix at the synapse requires further investigation. 
59 There is evidence that Alix may have a presynaptic role [9,17] but Alix has also been 
60 found within the human postsynaptic density (PSD) and is a CHMP4B binding protein 
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61 within the PSD associated ESCRT-III complex [18,19]. Therefore there is potential for 
62 Alix to facilitate intracellular ‘cross talk’ between neurotransmitter signalling pathways 
63 as well as modulate downstream signaling cascades following receptor stimulation. Given 
64 that dopamine receptors also interact with NMDARs [20,21], there is a well documented 
65 interaction between dopamine and glutamate signalling [22] and NMDARs are a central 
66 component of the PSD and have the capacity to trigger Ca2+-dependent neuronal cell 
67 death, we hypothesized that Alix may be able to influence NMDAR triggered cell death. 
68 Using heterologous expression of recombinant proteins in HEK293 cells, we 
69 examined the effect of Alix coexpression on NMDAR triggered cell death. Our results 
70 suggest that Alix is able to enhance NMDAR cell death in low or absent 
71 glutamate/glycine concentrations.
72 Materials and Methods
73 Plasmid cDNAs
74 cDNA plasmids for  Alix (GFP tagged in pCMVTag2C) have been previously described 
75 [14]. Flag tagged mouse Alix (in pCI) and the Alix deletion mutants have been published 
76 [17]. The NMDAR subunit cDNAs GluN1 and GluN2A in pRK7 have been reported 
77 previously [23]. 
78
79 Cell culture and transient transfections of plasmid cDNAs
80 HEK-293 cells were cultured in DMEM medium (Minimum Essential Medium,  
81 Modification [-MEM]) supplemented with 50 mg/ml Gentamycin, 4 mM L-glutamine, and 
82 10 % fetal bovine serum). Cells were plated at a density of 2 × 105 cells/1 ml DMEM 
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83 medium onto each well of a 24 well tissue culture plate and incubated in a 5% 
84 CO2 incubator at 37 °C for 24 hours.
85
86 Cells were transiently transfected using lipofectamine 2000 (Invitrogen). The DNA 
87 plasmid / lipofectamine mix and 100 µl of DMEM medium (without FBS, L-glutamine 
88 and antibiotics) were added to each well of a 24 well plate with 1 ml of medium 
89 containing attached cells at approximately 50-85% confluency. Cells were left for 18- 
90 20 hours at 37 °C in a 5% CO2 incubator. In experiments that used two, three or four 
91 different plasmids, equal concentrations of plasmids were added (total DNA 
92 concentration, 3 µg per well). To control for the effects of EGFP expression on cell death, 
93 pEGFP-N1 cDNA was added for GluN1/GluN2A only transfections. Transient 
94 transfections were performed with 10 µl lipofectamine/well. Using fluorescent cell 
95 counting, we observed maximal transfection efficiency of approximately 80 % for both 
96 GFP and GFP-tagged hAlix.
97
98 Western blotting
99 HEK-293 cells were grown to a density of 1.2 × 106 cells and transiently transfected and 
100 treated as described above. Cells were trypsinised, spun down and washed twice with 
101 PBS. The pellet was then left in 2 ml 1/2x protease inhibitor (Roche) on ice for 1 hour, 
102 homogenised and then spun down at 16,000 rpm for 15 minutes. The pellet was 
103 solubilized with buffer Px to a 1:1 ratio (0.2 M sodium phosphate pH 7.5, 1 % Triton X-
104 100 and supplemented with protease inhibitors) on ice for 1 hour. It was then spun down 
105 at 16,000 rpm for 2 minutes and the supernatant collected. 
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106 The concentration of the protein extract was determined by Bradford’s Protein Assay. 
107 Protein samples were loaded on a 4-12 % pre-cast NuPage gel in XCell Sure Lock mini 
108 gel system (Invitrogen). The separated polypeptides were transferred to 0.45 µm 
109 nitrocellulose by electroblotting in 1 x transfer buffer (NuPage 20x transfer buffer, 
110 Invitrogen) using the Bio Rad mini system. The nitrocellulose paper was then blocked 
111 with blocking buffer (50 mM Tris Base, 150 mM NaCl, 0.1 % Tween-20 with 5 % milk) 
112 and aspirated immediately with SNAP i.d. (Merck Milipore) and washed three times with 
113 TBS-T (50 mM Tris Base, 150 mM NaCl, 0.1 % Tween 20). The blot was incubated with 
114 the mouse anti-Alix [3A9] antibody (1:100 dilution, Abcam, ab117600) or mouse anti-
115 GluN1 [54.1] (1:1000 dilution, BD Biosciences) overnight and then IRDye 800 goat anti-
116 mouse (Licor) for 10 minutes and washed 3 times with TBS-T. The bound antibodies 
117 were visualized with the Odyssey Licor imaging system.
118
119 Synaptosomal preparation
120 This was based on a previously published protocol [24]. Adult rat cerebral cortex was 
121 removed, homogenized in cold isolation buffer (5 mM HEPES, 0.32 mM sucrose, pH 
122 7.4) and centrifuged (1,500 g). The pellet was resuspended in 0.32 M sucrose, 1 mM 
123 NaHCO3 and layered over a sucrose gradient (1.2/1/0.85 M) before centrifugation 
124 (70,000 g). The synaptosomal layer was harvested and resuspended in sodium 
125 resuspension media (2.5  mM HEPES, 8 mM KCl, 110 mM NaCl, 2.6 mM CaCl2,  10 
126 mM glucose, pH 7.4).
127  
128 Primary cortical cultures
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129 E18 rat embryos were terminated under Schedule 1 Home Office procedures (UK). After 
130 removal of the skull, the brain was placed dorsal side up and noncortical tissue was 
131 removed. The remaining cortical tissue was placed in ice cold PBS and chopped into 
132 small pieces. The tissue was then incubated for 20 minutes in 1 ml of 25  % trypLE/PBS 
133 solution at 37 °C before trituration in 37 °C DMEM. The solution was centrifuged at 
134 1500 rpm and the cell pellet was resuspended in 1 ml Neurobasal medium supplemented 
135 with 2 % B27 serum free supplement, 1 % penicillin/streptomycin, 300 µM glutamine 
136 and 25 µM β-mercaptoethanol. The cells were plated at an approximate density of 2 x 105 
137 per well of a 24-well plate. Neurones were maintained in culture for 14 days before use 
138 with fresh media added every 3-5 days.
139 Immunofluorescence 
140 Transiently transfected HEK 293 cells were cultured at a density of 1.75 × 10
5 
cells in 24 
141 well plates on glass cover slips coated with 100 µg/ml poly-D-lysine. The cells were then 
142 fixed with 4 % Paraformaldehyde (PFA) for 10 min and washed three times with PBS on 
143 ice.  Fixed cells were blocked with PBS containing 5 % horse serum and 0.1 % Tween-20 
144 for 45 minutes at room temperature. The cells were then incubated with the appropriate 
145 primary (mouse anti-Alix, Abcam, 1:100 dilution, rabbit anti-PSD95, Abcam ab18258, 
146 1:500 dilution mouse anti-EEA1, BD Biosciences, 610456, 1:1000 dilution) and 
147 secondary antibodies (Alexa Fluor 488 Goat anti-mouse secondary antibodies, Invitrogen, 
148 1:1000 dilution) for 1 hour each before embedding. Nuclei were stained with Hoechst 
149 33342 (Sigma) for 5 minutes at room temperature. F-actin was stained with TRITC-
150 conjugated rhodamine-phalloidin (77481, Sigma) diluted in PBS for 30 minutes at room 
151 temperature. Following staining, cells were embedded using the ProLong Gold reagent 
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152 (Invitrogen). The stained cells were visualised under a spinning disc confocal system 
153 (CARV from Digital Imaging Solutions) with an EM-CCD camera (Rolera/QI Cam 
154 3500) mounted on an Olympus X71 microscope, using a 100 x fluoplan objective. The 
155 microscope confocal system was supported by Image Pro 6.0 software. The same 
156 protocol was used to fix and stain primary cortical neurones after 14 days in vitro. The 
157 degree of colocalisation within a region of interest was performed using ImageJ. The 
158 colocalisation coefficients of each fluorophore pair were plotted as a scatter plot and a 
159 mean Pearson correlation coefficient was calculated to indicate the degree of 
160 colocalisation.
161 NMDAR triggered cell death assay
162 The trypan blue exclusion assay to measure the extent of glutamate receptor triggered cell 
163 death has been described previously [25] [26] [27]. Cells were exposed to various 
164 treatments 18-20 hours after the start of the transfection. Control cells were incubated in a 
165 physiological salt solution (PSS; 140 mM, NaCl; 1.4 mM CaCl2; 5.4 mM KCl; 
166 1.2 mM NaH2PO4; 21 mM glucose; 26 mM NaHCO3; pH 7.4) for 10 min in a 5% 
167 CO2 incubator at 37 °C. Activation of NMDARs was performed by incubating the cells in 
168 PSS containing 1 mM NMDA (Tocris) and 50 µM glycine (Sigma) for 10 min. After the 
169 10-min treatment, cells were placed in fresh media for six hours before assessment of 
170 cell death. 100 µM APV (Tocris) was added to each well to block any NMDAR 
171 activation before NMDA/glycine or PSS treatment.
172 Cell death was assessed by trypan blue exclusion after trypsinisation. This was 
173 determined by removing the PSS and media from each well and adding trypan blue (1:1 
174 ratio). The number of stained cells and unstained cells were counted using a 
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175 haemocytometer and calculated as a percentage of total cells. This was performed on 
176 cells attached to the well surface and on cells floating in the media or PSS. The 
177 percentage of stained or unstained cells from both attached and floating cells were 
178 combined to give a percentage cell death. All data points correspond to the mean ± SE of 
179 values performed from at least three separate transfections. 
180
181 Curve fitting and statistical analysis
182 Igor Pro 6.12 (Wavemetrics) was used to fit dose-response curves of NMDAR triggered 
183 cell death with the Hill equation below:
184
185 I = Imax/{1+(EC50/[A])nH}
186
187 nH is the Hill coefficient, Imax is the maximum level of cell death, [A] is the concentration 
188 of agonist (NMDA) and EC50 is the concentration of agonist that produces a half-
189 maximal response. Statistical comparisons of cell death between groups were performed 
190 using ANOVA followed by post-hoc Tukey’s test to determine statistical significance.
191 Results 
192 In order to confirm efficient expression of the human N-terminal GFP tagged Alix protein 
193 in HEK293 cells (Figure 1A), we detected Alix expression using Western blotting and 
194 confocal microscopy (Figure 1). A distinct band was detected in protein extracts from 
195 Alix transfected cells but not untransfected cells (Figure 1B). In addition we also 
196 examined NMDAR GluN1 subunit expression and detected no changes when 
197 coexpressed with Alix (Figure 1B). We also confirmed GFP-tagged Alix expression 
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198 using confocal microscopy (Figure 1C-H). HEK293 cells transiently transfected with 
199 human GFP-tagged Alix displayed strong cytoplasmic expression in agreement with 
200 previous studies [7,14]. This localization was similar when Alix was transfected alone 
201 (Figure 1C-E) or coexpressed with NMDARs (Figure 1F-H). Furthermore we also 
202 visualized GluN1 expression in cells coexpressed with Alix (Figure 1I-J).  There is 
203 literature supporting Alix expression at postsynaptic locations [18,19] and we examined 
204 the expression of Alix in different subcellular extractions from rat brain (Figure 2A). We 
205 detected a distinct Alix band in the synaptosomal fraction compared to other fractions or 
206 adult brain homogenate which supports synaptic expression of this protein. Furthermore, 
207 we also examined endogenous Alix expression in rat primary cortical cultures. Alix 
208 displayed punctate staining in the cytoplasm with little expression in the nucleus (Figure 
209 2B-E). We examined whether this would be similar to proteins such as PSD-95 that are 
210 known to show postsynaptic localization. We observed a similar punctate expression in 
211 both Alix and PSD-95 stained cells (Figure 2F-I). Alix is involved in multivesicular body 
212 sorting and receptor trafficking [8,28] but this has not been observed in neurones. To 
213 investigate this we examined the expression of the Early Endosome Antigen 1 (EEA1) 
214 which is a known marker for early endosomes. EEA1 staining showed a punctate pattern 
215 of expression and there was some overlap with Alix expression (Figure 2J-M). 
216 Colocalisation scatter analysis showed little correlation between Alix and Hoechst 
217 staining (mean Pearson correlation coefficient = -0.133 ± 0.12, n=3) consistent with the 
218 cytoplasmic expression of Alix. However we observed a more positive correlation 
219 between Alix and PSD95 (0.496 ± 0.08, n=3) and Alix and EEA1 (0.406 ± 0.07, n=3) 
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220 staining. Therefore Alix shows some expression at postsynaptic sites and endosomes 
221 which is consistent with previous reports.
222 We expressed GFP tagged human Alix together with GluN1 and GluN2A 
223 NMDAR subunits in HEK293 cells and examined NMDAR triggered cell death (Figure 
224 3A and B). We found that cells expressing GluN1/GluN2A subunits treated with 1 mM 
225 NMDA/50 µM glycine had a mean cell death of 27.4 ± 1.4 % (Figure 3A). Whereas, cells 
226 expressing GluN1/GluN2A subunits and treated with physiological salt solution had a 
227 mean cell death of 11.6 ± 0.7 % (Figure 3B). These results are similar to those reported 
228 by Wagey et al., 2001 [25] and confirmed expression of functional NMDARs. 
229 Coexpression of Alix with NMDARs and treating them with NMDA/glycine also 
230 produced a significant level of cell death but this was less than that seen with cells only 
231 expressing GluN1/GluN2A (mean cell death of 21.6 ± 1.9 %, Figure 3A, ANOVA, 
232 p<0.01). In contrast cells transfected with Alix alone had little effect on cell death and 
233 was not significantly different from lipofectamine only controls.
234 However in the absence of NMDA/glycine treatment, cells expressing 
235 NMDARs+Alix displayed a high level of cell death (mean cell death of 17.3 ± 1.0 %, 
236 Figure 3B). This level of cell death was significantly higher than cell only controls (mean 
237 cell death=11.9 ± 0.7 %), Alix only cells (mean cell death=12.4 ± 0.8 %) or cells only 
238 expressing NMDARs (11.6 ± 0.7 %) (ANOVA p<0.001). This indicates that  
239 GluN1/GluN2A/Alix transfection enhanced the basal level of cell death in the absence of 
240 NMDA. Therefore this would suggest that coexpression of Alix is exerting an influence 
241 on NMDAR triggered cell death especially at low levels of NMDAR activation or low 
242 agonist concentrations.
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243 We next repeated the NMDAR cell death assay in the presence of the competitive 
244 NMDAR antagonist, APV to confirm that the effects induced by Alix in the absence of 
245 NMDAR activation were directly caused by stimulation of the NMDA receptor (Figure 
246 3C). We found that by adding APV to the medium during NMDA/glycine treatment 
247 reduced cell death seen in Figure 3A (Mean cell death GluN1/GluN2A=9.8 ± 1.9 %, 
248 Mean cell death GluN1/GluN2A/Alix=9.3 ± 2.8 %) to similar levels seen in the cells only 
249 control (Mean cell death=8.3 ± 1.3%). In the presence of APV, the enhanced cell death 
250 seen in the absence of NMDA/glycine in cells transfected with GluN1/GluN2A/Alix was 
251 abolished (Figure 3D, mean cell death=11.7 ± 4 %). Furthermore, we excluded the 
252 influence of the GluN1 or GluN2A expression vectors by repeating the cell death assay 
253 with cotransfections of Alix and GluN1 or Alix with GluN2A and found that there was no 
254 significant change in cell death compared to the cells only control in the absence or 
255 presence of NMDA/glycine (Figure 3E and F). Therefore the increased levels of cell 
256 death seen in cells transfected with NMDAR + Alix (Figure 3B) require the formation of 
257 functional NMDARs and NMDAR activation. 
258 The enhanced NMDAR cell death in cells expressing Alix/NMDARs (Figure 3B) 
259 suggest that cells expressing NMDAR+Alix exhibit an increased sensitivity to lower 
260 concentrations of glutamate/glycine. Basal levels of cell death have been attributed to low 
261 levels of amino acids present within the culture media which could stimulate functional 
262 NMDARs expressed in GluN1/GluN2A transfected cells [25]. We examined this further 
263 by measuring the extent of cell death under a range of NMDA concentrations (0.1 mM, 
264 0.3 mM, 0.7 mM, 1 mM) on cells expressing GluN1/GluN2A NMDARs or 
265 GluN1/GluN2A NMDARs +Alix (Figure 4). Higher levels of cell death were observed in 
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266 the presence of Alix at low concentrations of NMDA (0.1-0.3 mM) compared to cells 
267 expressing only GluN1/GluN2A subunits. This further supported our assumption that the 
268 expression of Alix is lowering the NMDA concentration required to trigger maximal 
269 levels of cell death in our assay (>20 %) and suggests that the enhanced cell death in the 
270 presence of Alix seen in non treated cells is probably caused by low levels of NMDAR 
271 activation. Estimation of the NMDA EC50s also endorsed a higher NMDA sensitivity in 
272 cells expressing Alix (NMDA EC50=0.8 ± 0.01 mM for GluN1/GluN2A cells versus 
273 NMDA EC50=0.10 ± 0.02 mM for GluN1/GluN2A/Alix cells). Therefore this would 
274 imply that Alix is increasing the potency of NMDAR triggered cell death compared to 
275 cells only expressing NMDARs.
276 We then investigated the regions of Alix which might be responsible for our 
277 observations in Figure 3B. The Alix protein contains a number of functional domains and 
278 proline-rich amino acid residues within the N-terminal and C-terminal regions of Alix. 
279 The N- and C-terminal regions are linked by a stretch of amino acid residues containing 
280 two coiled-coil domains [29](Figure 1A). Therefore to confirm our observations were not 
281 specific to the human Alix sequence or influenced by the GFP-tag, we coexpressed 
282 wildtype and deletion mutants of mouse Alix (mouse FLAG tagged Alix WT, mouse Alix 
283 NT (N-terminal regions covering amino acids residues 1 to 434) and mouse  Alix CT (C-
284 terminal regions covering amino acid residues 468 to 869) to determine the effect these 
285 variants had on the NMDAR cell death assay (Figure 1A, Figure 5). Cells transfected 
286 with wildtype mouse Alix produced a similar pattern as the human Alix when 
287 coexpressed with NMDARs (Figure 5A and B). Mouse Alix reduced the toxicity 
288 associated with NMDA receptor stimulation when treated with NMDA/glycine (Mean 
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289 cell death=18.6 ± 1.9 %) compared to GluN1/GluN2A only cells (Mean cell death=23.1 ± 
290 1.1 %), but this difference was not found to be statistically significant. However we 
291 observed enhanced cell death in the absence of NMDA/glycine treatment (Mean cell 
292 death=15.6 ± 1.1 %) compared to cells only (Mean cell death=9.3 ± 0.9 %) or 
293 GluN1/GluN2A only cells (8.2 ± 0.4 %, ANOVA, p<0.01) (Figure 5B). We examined 
294 whether the Alix deletion mutants also showed elevated cell death in the absence of 
295 NMDA/glycine. AlixCT/NMDAR cells displayed an elevated level of cell death 
296 compared to NMDAR only cells (Mean cell death=15.9 ± 0.3 % vs NMDAR only mean 
297 cell death=11 ± 1.1%, ANOVA, p<0.05, Figure 5C). But this was not seen with 
298 AlixNT/NMDAR cells (Mean cell death=11.3 ± 0.3 %, Figure 5D), compared to cells 
299 only controls (Mean cell death=10.6 ± 0.3 %, Figure 5D) or cells expressing 
300 GluN1/GluN2A subunits only (Mean cell death=10.3 ± 0.4 %, Figure 5D). Therefore, this 
301 supports the conclusion that the C terminal domain of the Alix protein is responsible for 
302 the enhanced NMDAR cell death seen in the absence of NMDA/glycine described in 
303 Figure 3B.
304 Previous work has shown that the Ca2+-dependent interaction between Alix and 
305 ALG-2 is thought to be important for triggering cell death and this interaction involves a 
306 proline rich region (residues 802-813) within the C-terminal domain [11]. To examine 
307 whether our observations are dependent on the Alix-ALG-2 interaction, we expressed an 
308 Alix mutant (mouse deltaPRD) spanning amino acid residues 1-717 [17] (Figure 1A, 
309 Figure 5E). In the absence of NMDAR stimulation, we still observed a significantly 
310 elevated level of cell death (Mean cell death=17.5 ± 0.2 % vs NMDAR only mean cell 
311 death=10 ± 0.5%, ANOVA, p<0.001) compared to controls similar to that seen in the 
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312 presence of the AlixCT mutant (Figure 5E). Therefore other domains within the Alix C-
313 terminal domain are responsible for the enhanced level of cell death under these 
314 conditions and imply the involvement of a signalling pathway or interaction that could be 
315 independent of ALG-2-Alix binding.
316 Discussion
317 This is the first report describing the potential functional interaction of Alix and 
318 glutamate receptors. Our results from heterologous expression of recombinant Alix and 
319 NMDARs suggest that Alix could influence the downstream effects of NMDAR 
320 activation and highlight a potential role of the C-terminal region of the Alix protein in 
321 increasing the sensitivity of NMDARs to trigger cell death. Our partial dose-response 
322 curves suggest that the coexpression of Alix decreased the NMDA EC50 for inducing cell 
323 death by 7 fold compared to NMDARs expressed alone. However, the NMDA EC50 
324 values measured in the cell death assay differ quite considerably compared to those 
325 measured in other systems where recombinant NMDA receptor function has been 
326 recorded by oocyte electrophysiology (NMDA EC50 = 47 µM) [30]. There are a number 
327 of reasons for this discrepancy and this has probably been influenced by the transfection 
328 efficiency of both GluN1 and GluN2A subunits within the same cell, the ability to detect 
329 changes in cell death over prolonged periods of time and the influence of multiple second 
330 messenger pathways needed before cell death is detected. Nevertheless there is common 
331 agreement that EC50 values cannot be easily compared across different tissue 
332 systems/assay measurements and their interpretation has to be used appropriately [31].
333 Our data does suggest that some regions within the Alix C-terminal domain 
334 excluding the proline-rich region directly/indirectly enhance cell death as long as there is 
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335 sufficient NMDAR activation (and presumably Ca2+influx). The role of a number of 
336 domains linked with cell death processes have been identified within the N-terminal 
337 domain (Bro1 interaction with CHMP4) and the proline-rich region within the C-terminal 
338 domain (endophilins and ALG-2) [11,32]. Furthermore, the route of Ca2+ entry also has 
339 important implications for cell death [2] and dissecting the precise necrotic or apoptotic 
340 mechanisms underlying NMDAR cell death can be complex and depend on the 
341 intensity/duration of glutamate stimulation [33,34]. In addition we cannot exclude the 
342 possibility that Alix might influence the kinetics of NMDAR inward currents upstream of 
343 any intracellular signalling cascades following receptor activation. Therefore any 
344 upregulation of these signalling cascades, possibly by slowing the deactivation of 
345 NMDAR currents (and thus increase Ca2+ influx) could explain the leftward shift of the 
346 dose-response curve in the presence of Alix. However, is there evidence for Alix 
347 expressed at synaptic sites? Although we have not demonstrated a direct interaction with 
348 NMDARs, there are several lines of evidence supporting the potential for close 
349 localisation. Firstly, Alix is found within the postsynaptic density [18,19] and secondly 
350 Alix is known to interact with dopamine receptors [14] and can alter pharmacological 
351 properties. Furthermore, there are known direct protein interactions between dopamine 
352 receptors and NMDARs [20,21] and both receptors can form dynamic cell surface 
353 clusters in neurones near glutamatergic synapses [35] and even if Alix does not interact 
354 directly, there would be potential opportunities for Alix to influence signalling 
355 downstream of NMDARs. 
356 It is unclear why Alix was able to reduce cell death in the presence of 
357 NMDA/glycine when coexpressed with NMDARs (Figure 3A). Our observations suggest 
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358 that this requires NMDAR expression and NMDAR activation (Figure 3C-F). Previous 
359 work has shown that overexpression of the Alix C-terminal domain can inhibit apoptotic 
360 processes and reduce neuronal cell death by blocking Alix interaction with endogenous 
361 ALG-2 [7] [11] [10,32]. The interaction between Alix and ALG-2 occurs through its C-
362 terminal proline-rich region and is known to be Ca2+ dependent [7] [6]. ALG-2 is 
363 endogenously expressed in HEK293 cells [7] and the protein levels of Alix to ALG-2 
364 could have important implications for cell death. However from our data expression of 
365 the Alix mutant lacking the proline-rich region in the C-terminal still displayed high 
366 levels of NMDAR triggered cell death in the absence of NMDA/glycine.
367 There is strong evidence that endogenous Alix is highly expressed in neurones 
368 following transient and chronic neuronal insults. Hemming et al., 2004 [9] found that 
369 Alix expression was increased in areas of high c-fos expression and in dying neuronal 
370 cell bodies after kainate induced neurodegeneration. Increased Alix expression persisted 
371 24 hours after kainate injection in the piriform cortex and it has been postulated that Alix 
372 may play an early role in the cell death mechanism. To support this, Blum et al., 2004 
373 [36] also found Alix upregulation in neuronal cell bodies within the cortex and lateral 
374 striatum following chronic neurodegeneration by 3-nitropropionic acid. However, it is not 
375 completely clear whether Alix is a trigger or an early marker for neurodegenerative 
376 processes. Alix is known to be a component of the synaptic ESCRT-III complex 
377 associated with the spinoskeleton and loss of Alix has been shown to disrupt normal 
378 cytoskeletal organization within the cell [37]. Hence Alix may play an important role in 
379 supporting the structure of the PSD within dendritic spines [19]. The importance of 
380 maintaining a normal ESCRT-III complex is highlighted by C-terminal truncations in one 
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381 of the core components of the ESCRT-III complex, Chmp2b that have been linked to 
382 familial frontotemporal dementia [38]. 
383 In summary, we have identified a potential role for Alix with NMDAR activation 
384 and given the proximity of both of these proteins within the postsynaptic density could 
385 indicate an additional route by which NMDAR downstream signalling may be modified 
386 during neuronal cell death. Nevertheless, further work is required to fully elucidate the 
387 potential contribution of Alix in these downstream signalling cascades.
388
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522 Figure Legends
523
524 Figure 1- Expression and intracellular distribution of transiently transfected GFP-tagged 
525 Alix in HEK293 cells. A. Schematic diagram of human and mouse Alix cDNAs 
526 expressed in HEK 293 cells. Green region indicates location of GFP tag, red region 
527 indicates the predicted Bro1 sequence and the grey region indicates the proline rich 
528 domain. B. Western blotting confirmed expression of recombinant GFP-hAlix at 123 kDa 
529 (top) and GluN1 (bottom) at 108 kDa in transfected HEK293 cells (arrowhead) which 
530 was absent in cell only lysates. Intracellular distribution of Alix is shown in C-E (cells 
531 expressing Alix alone) and F-J (cells expressing Alix with NMDARs). Green 
532 fluorescence denotes Alix expression (C and F)) while blue corresponds to Hoechst 
533 33342 stained nuclei (D and G). The merged image of panels C-D and F-G is shown in E 
534 and H respectively. I-J. Cells expressing NMDARs were also stained for GluN1 
535 expression and the merged image with Alix expression (F) is shown in J. Scale Bar: 10 
536 μm. Anti-GluN1 mouse antibody (BD Biosciences, 1:1000 dilution), Alexa Fluor 488 
537 Goat anti-mouse (Invitrogen, 1:1000 dilution).
538
539 Figure 2- Expression of endogenous Alix from rat brain synaptosomal fractions and 
540 intracellular distribution in rat primary cortical neurones. A. Western blot showing 
541 endogenous expression of GluN1 (108 kDa) and Alix (96 kDa) in different subcellular 
542 fractions from adult rat brain. Syn, synaptosomal, LM, light membrane, Myl, myelin, 
543 Mito, mitochondrial and Ad, adult rat brain homogenate. B-M. Immunocytochemistry 
544 from rat primary cortical neurones (DIV14). Endogenous Alix expression is shown (B, 
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545 green, F and J, red) while blue corresponds to Hoechst 33342 stained nuclei (C, G, K) 
546 and red F-actin visualised with TRITC-conjugated rhodamine-phalloidin (D), rabbit anti-
547 PSD-95 (H) and mouse anti-EEA1 (L). The merged image of panels B-D is shown in E, 
548 F-H in I and J-L in M.  Scale Bar: 10 μm. Anti-Alix mouse antibody (Abcam, 1:100 
549 dilution), anti-PSD95 rabbit antibody (Abcam, 1:500 dilution), anti-EEA1 mouse 
550 antibody  (BD Biosciences, 1:1000 dilution), Alexa Fluor 488 goat anti-mouse and 
551 donkey anti-rabbit (Invitrogen, 1:1000 dilution).
552  
553  
554 Figure 3- Cotransfection of GFP tagged human Alix + GluN1/GluN2A NMDARs in 
555 HEK293 cells influences NMDAR triggered cell death. A. Mean percentage cell death 
556 measured by trypan blue exclusion following application of 1 mM NMDA/50 µM 
557 glycine, n=7-12. ** p<0.01 NMDAR only vs Alix+NMDAR B. Mean percentage cell 
558 death in PSS only exposure, n=7-14. *** p<0.001 NMDAR only vs Alix+NMDAR C. 
559 Mean cell death in the presence of 1 mM NMDA/50 µM glycine exposure + 100 µM 
560 APV, n=3. D. Mean cell death following PSS only exposure + 100 µM APV, n=3. E. 
561 Mean cell death following separate cDNA plasmid transfection + 1 mM NMDA/50 µM 
562 glycine exposure, n=3. F. Mean cell death following separate cDNA plasmid transfection 
563 + PSS exposure, n=3.
564
565 Figure 4- Partial NMDA dose-response curves of NMDAR triggered cell death in 
566 GluN1/GluN2A only and GluN1/GluN2A + Alix expressing cells. In the presence of Alix 
567 (grey filled circles), low concentrations (0.1-0.3 mM) of NMDA trigger far higher levels 
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568 of cell death compared to cells expressing GluN1/GluN2A only (black filled squares), 
569 n=3. Both dose-response curves were fit with the Hill equation predicting NMDA EC50 
570 =0.8 ± 0.01 mM (GluN1/GluN2A) and NMDA EC50 =0.10 ± 0.02 mM 
571 (GluN1/GluN2A+Alix). Dashed lines represent curves extrapolated to the basal levels of 
572 cell death.
573
574 Figure 5. Overexpression of wildtype mouse Alix and Alix deletion mutants influence 
575 NMDA triggered cell death.
576 Mean cell death was measured using trypan blue exclusion in the presence (A) and 
577 absence (B-E) of 1 mM NMDA/ 50 µM glycine. (A,B) Cotransfection of Flag tagged 
578 mouse Alix + GluN1/GluN2A NMDARs influences NMDAR triggered cell death. A. 
579 1mM NMDA/50 µM glycine exposure. B. PSS only exposure reveals enhanced cell death 
580 in the presence of Alix+NMDARs ** p<0.01 NMDAR only vs mouse Alix+NMDAR. C. 
581 Deletion mutants of mouse Alix displayed elevated cell death with AlixCT * p<0.05 
582 NMDAR only vs AlixCT+NMDAR. D. This was not seen with AlixNT in the presence 
583 of PSS. E. Removal of the PRD domain did not prevent NMDAR triggered cell death in 
584 the presence of PSS. *** p<0.001 NMDAR only cells vs mouse AlixdeltaPRD 
585 +NMDAR cells. All experiments n=3.
586
587
588
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